Expanding beyond CRC, MACC1 has also been shown to predict poor survival and metastasis formation in other biliodigestive cancers, including esophageal, gastric, cholangial, gallbladder, pancreatic and hepatocellular carcinomas [11–16]. Here, MACC1 is linked to hepatocellular carcinoma.